Targets › CNTF
1 program from 1 company in 2 trials: 2 Phase 2; Ophthalmology.
Functions as a cytokine through the ciliary neurotrophic factor receptor (CNTFR) complex. The CNTFR complex indeed consists of the membrane-anchored non-signaling receptor CNTFR and the two signaling receptor subunits IL6ST/gp130 and LIFR that transduce the signal into the cell. (UniProt, P26441)
Open in Phaseline: the race on CNTF, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Stanford University | NT-501 ECT implant Encapsulated cell therapy delivering ciliary neurotrophic factor (CNTF) | CNTF | Phase 2 | Glaucoma | – |
Glaucoma (2)
small molecule (1)
Stanford University (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.